Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Andrew P. Feinberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8364-1991; OpenAlex author ID A5074378026; NIH RePORTER profile ID 1894159. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper, 1 grant

Papers 2

  1. CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. Last author DOI 10.1186/s12943-026-02575-z↗
  2. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Last author DOI 10.1038/ng.3753↗

Grants 1

  1. Epigenetic drivers of cancer progression R01CA054358↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Maeda · 1 shared paper, 2026 · strength 0.24
  2. Jimin Min · 1 shared paper, 2026 · strength 0.24
  3. Barbara Stauch Slusher · 1 shared paper, 2026 · strength 0.24
  4. Anirban Maitra · 1 shared paper, 2026 · strength 0.24
  5. Alvin P. Makohon-Moore · 1 shared paper, 2017 · strength 0.05
  6. Oliver Gene McDonald · 1 shared paper, 2017 · strength 0.05
  7. Xin Li · 1 shared paper, 2017 · strength 0.05
  8. Yi Zhong · 1 shared paper, 2017 · strength 0.05
  9. Alessandro Carrer · 1 shared paper, 2017 · strength 0.05
  10. Hao Wu · 1 shared paper, 2017 · strength 0.05
  11. Kathryn Elaine Wellen · 1 shared paper, 2017 · strength 0.05
  12. Christine A. Iacobuzio–Donahue · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.